Novo dropped its patent-infringement case against telehealth provider Hims & Hers after the companies agreed that Hims would sell Novo's branded medicines.

Under the settlement, Genevant Sciences and Arbutus Biopharma will grant Moderna a non-exclusive license to their lipid nanoparticle technology for mRNA delivery in infectious disease vaccines. If ...

Alpha Modus (AMOD)resolved its patent infringement litigation against Brookshire Grocery Co. pending in the United States District Court for the Eastern District of Texas. The litigation involved ...

Moderna Inc.’s settlement to end a lawsuit over technology used in its Covid-19 vaccine caps its potential exposure at $2.25 ...

Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a fast-growing biopharmaceutical company committed to improving patient lives by developing and commercializing innovative products across a range of ...

Facial recognition and license plate reading tools that Immigration and Customs Enforcement and other Department of Homeland Security personnel are using in sweeps infringe five patents owned by a ...

First Solar has filed a Sec. 337 investigation request with the U.S. International Trade Commission (ITC) on a swath of crystalline silicon panel ...

A federal jury in Marshall, Texas, has ordered Samsung Electronics to pay nearly $445.5 million to Collision Communications for infringing patents related to 4G, 5G, and Wi-Fi network technology. The ...

In a recent patent case, the U.S. government urged a Texas federal court to give greater weight to the difficulty of calculating damages as a basis for finding irreparable harm. If embraced by courts, ...

Archer Aviation has filed a patent infringement complaint against Vertical Aerospace alleging that Vertical’s recently ...

AWS has removed its legal protections for customers using its video transcoding and streaming services, potentially exposing ...

The Federal Circuit’s recent decision in Range of Motion Products, LLC v. Armaid Company Inc. highlights a growing dissatisfaction with courts’ broad use of the sufficiently distinct/plainly ...